X4 PHARMACEUTICALS INC (XFOR) Stock Earnings Estimates
NASDAQ:XFOR • US98420X2027
3.44 USD
+0.05 (+1.47%)
Last: Feb 25, 2026, 08:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.557M | 34.929M 1,266.01% | 10.796M -69.09% | 23.93M 121.66% | 116.09M 385.12% | 297.02M 155.85% | 589.21M 98.37% | 256.24M -56.51% | 622.58M 142.97% | |||
| EBITDA YoY % growth | -87.57M -16.99% | -107.103M -22.31% | -140.605M -31.28% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -88.08M -16.89% | -107.522M -22.07% | -141.401M -31.51% | -87.609M 38.04% | -102.675M -17.20% | -110.151M -7.28% | -41.756M 62.09% | 85.202M 304.05% | 282.6M 231.68% | 199.28M -29.48% | 336.02M 68.62% | |
| Operating Margin | N/A | N/A | -5,529.96% | -250.82% | -951.05% | -460.30% | -35.97% | 28.69% | 47.96% | 77.77% | 53.97% | |
| EPS YoY % growth | -56.10 49.46% | -18.00 67.91% | -21.30 -18.33% | -2.79 86.91% | -1.10 60.49% | -1.05 4.63% | -0.38 63.59% | 0.53 238.67% | 1.74 227.88% | 0.87 -50.15% | 2.67 208.24% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 93.88% | -0.24 -703.51% | -0.24 93.14% | -0.24 65.51% | -0.24 35.19% |
| Revenue Q2Q % growth | 1.711M 19.32% | 3.978M -86.19% | 2.618M 32.69% | 2.72M 54.11% | 2.958M 72.88% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -25.213M 29.41% | -23.111M -144.74% | -22.733M 13.34% | -22.369M 18.69% | -21.864M 13.28% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.69 87.22% | -0.93 | 0.24 | 26.15% |
| Q2 2025 Q2Q % growth | -3.47 -65.24% | -4.42 | 0.95 | 21.58% |
| Q1 2025 Q2Q % growth | 0.04 100.51% | -4.53 | 4.57 | 100.88% |
| Q4 2024 Q2Q % growth | -6.00 -100.00% | -5.36 | -0.64 | -12.04% |
| Q3 2024 Q2Q % growth | -5.40 -1,700.00% | -5.29 | -0.11 | -2.09% |
| Q2 2024 Q2Q % growth | -2.10 78.79% | 0.17 | -2.27 | -1,301.88% |
| Q1 2024 Q2Q % growth | -7.80 -62.50% | -4.98 | -2.82 | -56.52% |
| Q4 2023 Q2Q % growth | -3.00 65.52% | -4.68 | 1.68 | 35.86% |
| Q3 2023 Q2Q % growth | -0.30 96.15% | -4.56 | 4.26 | 93.42% |
| Q2 2023 Q2Q % growth | -9.90 45.00% | -5.00 | -4.90 | -98.08% |
| Q1 2023 Q2Q % growth | -4.80 77.78% | -6.64 | 1.84 | 27.76% |
| Q4 2022 Q2Q % growth | -8.70 67.78% | -7.38 | -1.32 | -17.85% |
| Q3 2022 Q2Q % growth | -7.80 65.79% | -9.16 | 1.36 | 14.81% |
| Q2 2022 Q2Q % growth | -18.00 18.92% | -19.54 | 1.54 | 7.88% |
| Q1 2022 Q2Q % growth | -21.60 44.62% | -18.62 | -2.98 | -15.99% |
| Q4 2021 Q2Q % growth | -27.00 1.10% | -20.90 | -6.10 | -29.21% |
| Q3 2021 Q2Q % growth | -22.80 -2.70% | -22.11 | -0.69 | -3.13% |
| Q2 2021 Q2Q % growth | -22.20 2.63% | -22.61 | 0.41 | 1.79% |
| Q1 2021 Q2Q % growth | -39.00 -132.14% | -26.28 | -12.72 | -48.42% |
| Q4 2020 Q2Q % growth | -27.30 | -27.63 | 0.33 | 1.20% |
| Q3 2020 Q2Q % growth | -22.20 | -23.12 | 0.92 | 3.99% |
| Q2 2020 Q2Q % growth | -22.80 | -21.95 | -0.85 | -3.88% |
| Q1 2020 Q2Q % growth | -16.80 | -24.40 | 7.60 | 31.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.765M 215.18% | 2.083M | -318K | -15.27% |
| Q2 2025 Q2Q % growth | 1.973M 250.44% | 1.644M | 329K | 20.01% |
| Q1 2025 Q2Q % growth | 28.807M | 2.038M | 26.769M | 1,313.49% |
| Q4 2024 Q2Q % growth | 1.434M | 1.062M | 372K | 35.03% |
| Q3 2024 Q2Q % growth | 560K | 1.727M | -1.167M | -67.57% |
| Q2 2024 Q2Q % growth | 563K | 284.243K | 278.757K | 98.07% |
| Q1 2022 Q2Q % growth | 123.859K | -123.859K | -100.00% | |
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.26% | 24.21% | 0% | 25.97% |
| Revenue | -3.22% | -32.58% | 0% | -2.95% |